Navigation Links
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
Date:5/24/2013

HAYWARD, Calif., May 24, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reported Dr. Edward W. Knowlton has resigned as a member of the Company's Board of Directors effective immediately.  Dr. Knowlton is the founder of Thermage, the predecessor company to Solta Medical and had served as a director since 1996.

"On behalf of the entire Board of Directors, as well as our management team, I would like to thank Ed for his tireless dedication to our company and his numerous contributions," said Stephen J. Fanning , Chairman, President and CEO.  "Ed is a pioneer in the medical aesthetics industry having authored numerous patents in the field and written several scientific papers on plastic surgery.  We will miss his participation on our Board of Directors."

"Solta has emerged as the leading innovator in the medical aesthetics industry and is positioned to build returns for our shareholders," said Dr. Knowlton.  "After several years as a member of the Board, I've decided that now is an opportune time for me to leave my formal role with Solta.  As the Company's founder, Solta and the team will be always near and dear to me and they can always count on my help whenever I can be of assistance."

With Mr. Knowlton's resignation, Solta has seven directors.  The Board currently does not intend to add an eighth director.

About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative solutions with proven efficacy and safety backed by over 10 years of clinical study and research. The company offers aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin tightening, as well as tools and accessories to optimize the latest liposuction techniques. The Solta Medical portfolio includes the well-known brands Thermage®, Fraxel®, Clear + Brilliant®, Liposonix®, Isolaz®, CLARO®, VASERlipo, VASERshape, VASERsmooth, VentX®, PowerX®, TouchView®, and Origins, which collectively make up a comprehensive platform to address a range of aesthetic skin and body issues. More than two and a half million procedures have been performed with Solta Medical's products around the world. Solta Medical is headquartered in Hayward, CA with field teams and regional offices worldwide.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
2. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
3. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
4. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
5. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
6. Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
7. Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
8. Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors
9. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
10. DxInsights Names Ethan K. Knowlden Executive Director
11. Andrew Love Joins The Female Health Company Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... MEMPHIS, Tenn. , July 31, 2017 Three Tru-D ... in Yongsan, South Korea . Tru-D, short for "Total ... patient and operating rooms after an environmental services (ES) professional cleans the ... ... "Although ...
(Date:7/27/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... 30, 2017.  The Company reported second quarter net sales ... prior year period, and an increase of 2.1% on ... of contribution from the LDR Holding Corporation acquisition, second ... of 2016, or 0.3% on a constant currency basis. ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... “Prompted By Love”: a ... creation of published author, Mary Nettles. Author Mary P. Nettles has devoted her ... assistant VBS teacher. Her lifelong desire to write was, however, not fulfilled until ...
(Date:8/18/2017)... ... ... “Case #10-5411 Veterans Administration”: a personal account of corruption ... Administration” is the creation of published author, Carol Mulhern, single mother of two ... work at the Coatesville VAMC as a file clerk then later became the ...
(Date:8/17/2017)... ... August 17, 2017 , ... Shared leadership between ... extremely effective, very effective, or effective by 85% of respondents, according to the ... Insights Reports are based on surveys of the NEJM Catalyst Insights Council, a ...
(Date:8/17/2017)... , ... August 17, 2017 , ... When Amy ... stretcher side nurse, she took with her a dream to make nursing education more ... Specifically, ensuring communication skills were integrated into healthcare provider education. , ...
(Date:8/17/2017)... ... August 17, 2017 , ... CARF International announced that Inland ... residential drug and alcohol detox program. This accreditation decision represents the highest level ... substantial conformance to the CARF standards. , Behavioral health organizations receiving a Three-Year ...
Breaking Medicine News(10 mins):